Association of serum Maresin-1 levels with insulin-resistance indices in obese individuals

dc.contributor.authorDeniz, Levent
dc.contributor.authorYardim, Meltem
dc.contributor.authorSaltabas, Mehmet Akif
dc.contributor.authorAkkoc, Ramazan Fazil
dc.date.accessioned2026-08-12T16:58:20Z
dc.date.issued2025
dc.departmentFırat Üniversitesi
dc.description.abstractINTRODUCTION: This study aimed to investigate serum Maresin-1 (MaR1) levels among obese, overweight, and normal-weight groups, as well as to evaluate their association with various metabolic parameters, including insulin resistance-related indices and lipid profiles. METHODS: Ninety subjects were classified into three distinct groups in terms of body mass index (BMI). Using a median MaR1 value of 608 pg/mL as the threshold, the participants were also categorized into two distinct groups. Serum MaR1 levels were quantified via an ELISA. The study also evaluated several other indicators: metabolic score for insulin resistance (METS-IR), triglyceride glucose-body mass index (TyG-BMI), HbA1c, and various components of the lipid profile. RESULTS: MaR1 levels were significantly lower in the obese and overweight categories compared to the normal-weight categories. Nevertheless, no statistically significant difference was observed in the MaR1 levels between the obese and overweight groups. MaR1 levels were negatively linked to METS-IR (r=-0.444, p<0.001) and TyG-BMI (r=-0.427, p<0.001), whereas quantitative insulin sensitivity check index (r=0.318, p=0.002) levels were positively correlated. METS-IR had the highest AUC value (0.706), with 73.3% sensitivity and 57.8% specificity to identify high levels of MaR1 (p<0.001). DISCUSSION AND CONCLUSION: Ordinal logistic regression revealed a significant independent relationship between MaR1 levels and BMI categories. The close association between MaR1 and metabolic indices such as METS-IR and TyG-BMI suggests its role in insulin sensitivity and obesity-associated metabolic disorders.
dc.identifier.doi10.14744/ijmb.2025.59002
dc.identifier.endpage124
dc.identifier.issn2587-2362
dc.identifier.issn2618-642X
dc.identifier.issue2
dc.identifier.scopus2-s2.0-86000549083
dc.identifier.scopusqualityQ4
dc.identifier.startpage116
dc.identifier.trdizinid1353582
dc.identifier.urihttps://doi.org/10.14744/ijmb.2025.59002
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/1353582
dc.identifier.urihttps://hdl.handle.net/11508/46816
dc.identifier.volume8
dc.identifier.wosWOS:001635825400008
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakTR-Dizin
dc.language.isoen
dc.publisherKare Publ
dc.relation.ispartofInternational Journal of Medical Biochemistry
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WoS_20260511
dc.subjectInsulin resistance
dc.subjectMaresin-1
dc.subjectMETS-IR
dc.subjectobesity
dc.subjectspecialized pro-resolving mediators
dc.subjectTyG-BMI
dc.titleAssociation of serum Maresin-1 levels with insulin-resistance indices in obese individuals
dc.typeArticle

Dosyalar